Having trouble accessing articles? Reset your cache.

Elan, Royalty Pharma deal

Elan used $1 billion to repurchase 88.9 million shares, or about 14.8%, at $11.25 in a Dutch auction. The price was at the low end of the company's $11.25-$13

Read the full 290 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE